Medline’s multi-year leadership transition is officially underway, as the company named its new CEO and President/COO in a June 28 news announcement.
After more than 26 years of serving as the leaders of Medline, CEO Charlie Mills, President Andy Mills, and COO Jim Abrams will be retiring, the announcement said. All three will continue to serve on Medline’s board of directors, with Charlie Mills as Chairman, and Andy Mills and Abrams as Vice Chairmen.
Jim Boyle will take over as CEO, and Jim Pigott will be the next President/COO. Both Boyle and Pigott are currently Medline executives. The leadership transition “will be effective Oct. 1, 2023,” the announcement said.
In announcing the upcoming changes, Charlie Mills said in the news release, “Jim Boyle and Jim Pigott have been instrumental in Medline’s growth and success during their nearly 60 years combined within the organization, and we are excited for them to lead us into the future. In blending Medline’s high-performance culture and customer-centric approach with their extensive understanding of healthcare, they are perfectly suited to propel Medline forward while continuing to build upon our rich legacy.”
Boyle joined Medline in 1996 and has been the company’s Executive Vice President since 2018. Medline said Boyle has managed the company’s customer base of more than 5,000 healthcare providers while overseeing more than $21 billion of sales annually. During his Medline tenure, he has been the company’s Division Vice President and Senior Vice President of Medline’s acute care segment.
“I am incredibly honored by this opportunity,” Boyle said in the announcement. “I want to express my gratitude to the Mills family for their years of leadership and for the confidence placed in me to guide this organization forward. Medline has always been a company that operates in a nimble and agile manner, doing whatever is best for our customers and our employees, and I look forward to ensuring we continue to do so for years to come.”
Pigott has been with Medline since 1992 and most recently was the company’s Executive Vice President. In that role, he oversaw the strategy and execution of Medline’s 27 product divisions, which comprise more than 20 manufacturing sites and 14,000 employees. Pigott played key roles in Medline’s expansions into segments such as surgical, laboratory, diagnostics, and cardiology, and he led Medline’s global sourcing partnerships strategies while President of Medline Asia, a position he held for four years.
“I am proud of all that Medline and the Mills family have accomplished through the years for our customers, the healthcare industry, and especially in cultivating our winning company culture,” said Pigott. “I am grateful for this opportunity, and as we continue to find solutions to healthcare’s evolving challenges, I remain committed to doing so while preserving and building upon our company heritage.”
The news release said the announcement of Boyle’s and Pigott’s new roles was the culmination of a five-year Medline succession plan.